Internal Medicine, Hematology & Oncology · Grand Rapids, MI
NPI
1427059781
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
145 Michigan St NE, Suite 3100
Grand Rapids, MI, 49503
Phone (616) 954-9800
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
79,486 services
Medicare patients, 2024
368
Average age 72
Drug cost, 2024
$4.5M
2,085 prescriptions
Company payments, 2025
$150
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy C Vander Woude was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 1,524 times for 32 patients. In total Amy C Vander Woude billed 79,486 services in 173 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,524 | 32 | $0.09 | $137 |
| 36415 Venipuncture Blood Collection | Office | 596 | 153 | $8.60 | $5,126 |
| 85025 Blood Count | Office | 464 | 78 | $7.57 | $3,513 |
| 80053 Clinical Chemistry | Office | 406 | 77 | $10.31 | $4,187 |
| 96375 Injection Administration | Office | 353 | 39 | $10.81 | $3,817 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 326 | 45 | $4.51 | $1,471 |
| 99214 Office E&M - Established | Office | 280 | 155 | $86.70 | $24K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 260 | 12 | $0.75 | $195 |
| 96413 Chemotherapy Administration | Office | 240 | 60 | $87.41 | $21K |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 166 | 41 | $74.80 | $12K |
| 83735 Clinical Chemistry | Office | 94 | 20 | $6.57 | $618 |
| 86300 Immunoassay | Office | 94 | 25 | $20.02 | $1,882 |
| 96367 Intravenous Infusion, Hydration | Office | 92 | 22 | $19.95 | $1,836 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 87 | 14 | $0.66 | $57.5 |
| 99215 Office E&M - Established | Office | 83 | 61 | $128.14 | $11K |
By year: 2022 $901K for 38,660 services; 2023 $1.4M for 64,083 services; 2024 $1.5M for 79,486 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 596 | 153 | $8.60 | $5,126 |
| 85025 Blood Count | 464 | 78 | $7.57 | $3,513 |
| 80053 Clinical Chemistry | 406 | 77 | $10.31 | $4,187 |
| 83735 Clinical Chemistry | 94 | 20 | $6.57 | $618 |
| 86300 Immunoassay | 94 | 25 | $20.02 | $1,882 |
| 82306 Clinical Chemistry | 81 | 76 | $28.76 | $2,330 |
| 82565 Clinical Chemistry | 60 | 40 | $5.02 | $301 |
| 84466 Clinical Chemistry | 29 | 18 | $12.50 | $363 |
| 82728 Clinical Chemistry | 29 | 19 | $12.97 | $376 |
| 83540 Clinical Chemistry | 29 | 18 | $6.34 | $184 |
Medicare prescription drug claims, 2024
In 2024, the drug Amy C Vander Woude prescribed most often to Medicare patients was Anastrozole, with 572 prescriptions and refills. In total Amy C Vander Woude wrote 2,085 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 572 | 1,562 | 214 | $20K |
| Letrozole Generic | 260 | 706 | 93 | $10K |
| Ibrance Palbociclib | 172 | 172 | 20 | $2.6M |
| Exemestane Generic | 125 | 351 | 45 | $30K |
| Tamoxifen Citrate Generic | 120 | 341 | 46 | $5,148 |
| Prochlorperazine Maleate Generic | 79 | 79 | 46 | $1,064 |
| Gabapentin Generic | 51 | 70 | 15 | $539 |
| Olanzapine Generic | 48 | 50 | 23 | $139 |
| Alendronate Sodium Generic | 44 | 123 | 14 | $767 |
| Escitalopram Oxalate Generic | 39 | 91 | 14 | $599 |
| Omeprazole Generic | 36 | 44 | Under 11 | $320 |
| Kisqali Ribociclib Succinate | 35 | 35 | Under 11 | $540K |
| Eliquis Apixaban | 35 | 47 | Under 11 | $25K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 26 | 27 | 22 | $269 |
| Orserdu Elacestrant Hcl | 26 | 26 | Under 11 | $548K |
Brand drugs: 411 claims; generic drugs: 1,674 claims; opioid claims: 40.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy C Vander Woude $150 ($150 in general payments such as food, travel and fees) from 5 companies. The largest payer was Merck Sharp & Dohme LLC with $95.39.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.